Tesla deliveries are set to rise — no thanks to the U.S.

Tesla is expected to sell about 401,000–406,024 vehicles in Q2, implying up to +5.7% year-over-year growth, with limited upside as the U.S. EV market struggles to show a rebound. The forecast also suggests some improvement versus Tesla’s weaker March-quarter sales. Tesla reports Q2 delivery/sales numbers Thursday, which is likely to influence near-term sentiment given expectations for only modest growth.

Analysis

This setup is less about whether deliveries are up and more about what kind of growth is left. If Europe is doing the work while the U.S. stays soft, the market should discount the print as lower-quality volume that likely required more discounting, which limits any multiple expansion even if the headline comes in at the top end of expectations.

The second-order issue is mix: Europe-led strength tends to come from a more competitive, price-sensitive environment, so incremental units may contribute less to gross profit than a U.S. rebound would. That means the stock can look fine on units while the real risk is margin compression and weaker free-cash-flow conversion over the next 1-3 quarters, especially if the company has to keep incentives elevated to defend share.

The contrarian angle is that consensus may be too focused on the delivery number and not enough on trajectory. If this print is merely “not bad,” TSLA can still underperform because investors need evidence of a second-half U.S. re-acceleration; absent that, this starts to trade more like a mature auto OEM than a growth compounder. The thesis is falsified if the company pairs a modest unit beat with clear proof of improving U.S. demand and no further discounting pressure into Q3.

Key Decisions for Investors

• Stay neutral to slightly short TSLA into the delivery release; the risk/reward is poor for chasing a headline beat when the mix likely leans toward lower-margin Europe. Reassess only if the stock sells off on a miss or gaps up on a quality beat.
• If TSLA rallies on the print but management provides no evidence of U.S. re-acceleration, fade it with a 1-2 month put spread. Best entry is after an opening gap higher; invalidation is clear commentary on demand stabilization and reduced incentive intensity.
• For EV-beta exposure, consider a relative short KARS vs long TSLA over the next 1-3 months if Europe share gains look durable. This isolates TSLA's brand strength while hedging broader sector weakness; reverse the pair if the print shows the Europe lift was subsidy-driven rather than structural.
• Set a watch item on auto gross margin ex-credits and delivery mix in the next earnings call: if margin deteriorates despite higher units, treat the move as a false positive and reduce any long exposure immediately.